OTEZLA XR
Live / Applied — Fourth extension granted (statement of use) (as of 31 Mar 2025)
What this means for you
Not registered yet, but its 15 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97504938
- Mark type
- Stylized text
- Filed
- 15 Jul 2022
- Published for opposition
- 04 Apr 2023
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of chronic inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis and cancer
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 30 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 03 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2025 — SOU EXTENSION 4 GRANTED
- 31 Mar 2025 — SOU EXTENSION 4 FILED
- 31 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2024 — SOU EXTENSION 3 GRANTED
- 05 Aug 2024 — SOU EXTENSION 3 FILED
- 05 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Apr 2024 — SOU EXTENSION 2 GRANTED
- 15 Apr 2024 — SOU EXTENSION 2 FILED
- 15 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED